1-9 of 9
Julye Lavoie
Close
Sort by
Journal Articles

Salvage Therapy with Allogeneic Stem Cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared to Those with Transformed Non-Hodgkin Lymphoma: A Population-Based Comparative Study.

Khaled M Ramadan, MB, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, MD, Kevin W. Song, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 975.
https://doi.org/10.1182/blood.V112.11.975.975
Published: 2008
Journal Articles

Comparison of Outcome Between Refractory/Relapsed De Novo Diffuse Large B-Cell and Transformed Lymphoma Using Related and Unrelated Allogeneic Hematopoietic SCT.

Khaled M Ramadan, MB, Kevin W. Song, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 2173.
https://doi.org/10.1182/blood.V112.11.2173.2173
Published: 2008
Journal Articles

Impact of Comorbidity Index on Outcome with Allogeneic Hematopoetic Stem Cell Transplantation for Chronic Lymphocytic Leukemia

Cynthia L. Toze, MD, FRCP(C), Rauvynne N Sangara, Joseph M. Connors, MD, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Julye Lavoie, MD, Michael J Barnett, BMBS, Stephen H. Nantel, MD, FRCPC, Nicholas Voss, MD, Donna E. Hogge, MD, PhD, Heather J. Sutherland, MD, PhD, Donna L Forrest, Kevin W Song, Yasser Abou Mourad, Maryse M Power, Sujaatha Narayanan, Ryan Brinkman, PhD, Clayton Smith, MD, FRCPC
Journal: Blood
Blood (2008) 112 (11): 3305.
https://doi.org/10.1182/blood.V112.11.3305.3305
Published: 2008
Journal Articles

Autologous Stem Cell Transplantation Is Superior to Myeloablative Allogeneic SCT as a Salvage Therapy for Patients with Refractory/Relapsed Transformed Lymphoma

Khaled M Ramadan, MB, Joseph M. Connors, Abdul Al-Tourah, Randy D. Gascoyne, Kevin W. Song, Michael J. Barnett, Stephen H. Nantel, MD, FRCPC, Thomas J. Nevill, MD, FRCPC, John D. Shepherd, MD, Heather J. Sutherland, MD, PhD, Julye Lavoie, MD, Donna L. Forrest, Donna E. Hogge, MD, PhD, Nicholas Voss, MD, Ryan Brinkman, PhD, Yasser R. Abou Mourad, Maryse M. Power, Sujaatha Narayanan, Clayton A. Smith, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2008) 112 (11): 4459.
https://doi.org/10.1182/blood.V112.11.4459.4459
Published: 2008
Journal Articles

Allogeneic Stem Cell Transplantation as Treatment for Relapsed and High-Risk Peripheral T-Cell Lymphoma.

Hilary M. O’Leary, Kerry J. Savage, Cynthia L. Toze, Joseph M. Connors, Randy D. Gascoyne, Yasser Abou Mourad, Michael J. Barnett, Donna L. Forrest, Donna E. Hogge, Julye Lavoie, Stephen H. Nantel, Thomas J. Nevill, John D. Shepherd, Clayton Smith, Heather J. Sutherland, Nicholas Voss, Ryan Brinkmann, Kevin Song
Journal: Blood
Blood (2007) 110 (11): 3040.
https://doi.org/10.1182/blood.V110.11.3040.3040
Published: 2007
Journal Articles

Myeloablative Allogeneic Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade Lymphoma Is Not Superior to Autologous Stem Cell Transplantation - Reduced Relapse Risk Is Offset by Higher Treatment Related Mortality.

Khaled M. Ramadan, Joseph M. Connors, Abdulwahab J. Al-Tourah, Randy D. Gascoyne, Kevin Song, Michael J. Barnett, Stephen H. Nantel, Thomas J. Nevill, John D. Shepherd, Heather J. Sutherland, Julye Lavoie, Donna L. Forrest, Donna E. Hogge, Nicholas J. Voss, Clayton A. Smith, Cynthia L. Toze
Journal: Blood
Blood (2006) 108 (11): 3039.
https://doi.org/10.1182/blood.V108.11.3039.3039
Published: 2006
Journal Articles

Long Term Results of Myeloablative Allogeneic Stem Cell Transplantation Using Related and Unrelated Donors in Patients with Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.

Khaled M. Ramadan, Joseph M. Connors, Randy D. Gascoyne, Kevin Song, Michael J. Barnett, Stephen H. Nantel, Thomas J. Nevill, John D. Shepherd, Heather J. Sutherland, Julye Lavoie, Donna L. Forrest, Donna E. Hogge, Nicholas J. Voss, Ryan Brinkman, Clayton A. Smith, Cynthia L. Toze
Journal: Blood
Blood (2006) 108 (11): 3139.
https://doi.org/10.1182/blood.V108.11.3139.3139
Published: 2006
Journal Articles

Induction Therapy with High-Dose Dex Alone in Newly Diagnosed Myeloma Patients Produces a 57% Partial Response and Is Predictive of Progression Free Survival.

David A. Irvine, Michael J. Barnett, Ryan Brinkman, Donna L. Forrest, Donna E. Hogge, Julye Lavoie, Linda Lei, Stephen H. Nantel, Thomas J. Nevill, Janet Nitta, John Shepherd, Kevin Song, Cynthia Toze, Heather Sutherland
Journal: Blood
Blood (2006) 108 (11): 3098.
https://doi.org/10.1182/blood.V108.11.3098.3098
Published: 2006
Journal Articles

Prior Rituximab Reduces Relapse and Improves Survival Following High Dose Chemotherapy and Stem Cell Transplantation for Relapsed Composite Low and Intermediate Grade (Including Transformed) Lymphoma.

Khaled M. Ramadan, Joseph M. Connors, Abdulwahab J. Al-Tourah, Randy D. Gascoyne, Kevin Song, Michael J. Barnett, Stephen H. Nantel, Thomas J. Nevill, John D. Shepherd, Heather J. Sutherland, Julye Lavoie, Donna L. Forrest, Donna E. Hogge, Nicholas J. Voss, Ryan Brinkman, Clayton A. Smith, Cynthia L. Toze
Journal: Blood
Blood (2006) 108 (11): 3662.
https://doi.org/10.1182/blood.V108.11.3662.3662
Published: 2006